Retinal examination can help identify disseminated tuberculosis in patients with HIV/AIDS. by Saranchuk, P et al.
Retinal Examination Can Help
Identify Disseminated
Tuberculosis in Patients With
HIV/AIDS
TO THE EDITOR—We were surprised to
see that the recent article by Crump et al
on bacteremic disseminated tuberculosis
in sub-Saharan Africa [1] overlooked the
value of retinal examination in detection
of disseminated tuberculosis. Unfortu-
nately, inattention to eye manifestations
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 of tuberculosis is all too common, in-
cluding in World Health Organization
(WHO) guidelines [2], despite having
been acknowledged by Sir William Osler
more than a century ago [3].
Detecting choroidal tuberculosis by
indirect ophthalmoscopy allows for an
easy and rapid diagnosis of disseminated
tuberculosis in a meaningful number of
patients with human immunodeﬁciency
virus (HIV) infection and low CD4 cell
counts. We explored the feasibility of
this strategy in a prospective clinical
series of 192 patients from southern
Africa (Lesotho, 18 clinics in rural South
Africa, plus the urban township of
Khayelitsha) (Table 1). Patients were ex-
amined by an HIV clinician (M. B.)
with prior formal training in indirect
ophthalmoscopy, including detection of
choroidal tuberculosis. Inclusion criteria
consisted of CD4 cell count <50 cells/µL
or WHO clinical stage 4 disease (if CD4
cell counts were unavailable). Indirect
ophthalmoscopy through fully dilated
pupils was performed after patients had
been routinely screened for tuberculosis
by symptom complex, sputum smear or
culture, or chest radiography. Of note,
choroidal tuberculosis was identiﬁed in
5 of 84 patients who had prior negative
tuberculosis screening results and in
whom it subsequently led to a decision
to initiate tuberculosis treatment.
Our ﬁndings are supported by others:
choroidal tuberculosis was identiﬁed in 3
(5.7%) of 53 HIV-positive mycobactere-
mic patients from Malawi [4] and in 6
(60%) of 10 patients with mycobacterial
sepsis from Mumbai [5]. In prospective
cross-sectional studies, an HIV clinic re-
ported 4 of 17 patients (23.5%) with eye
lesions [6], and a general hospital report-
ed 18 of 100 patients (18%) with ocular
ﬁndings of tuberculosis (11 of 18 pa-
tients were HIV positive) [7].
Diagnosis of disseminated tuberculo-
sis in advanced immunodeﬁciency is
difﬁcultbecausepatientsoftenhaveatypi-
cal or normal chest radiographs, and/or
sputum that is unobtainable or negative
at smear microscopy [1, 8]. Diagnosis is
not made until autopsy in up to half of
patients [8], and the syndrome is lethal,
with almost 50% mortality after about 1
month [1]. In resource-limited settings,
with erratic or absent technological
support, the challenge is daunting. The
article by Crump et al highlights the
constraints that exist in resource-limited
settings: a CD4 cell count was available
for only 31% of bacteremic patients [1].
A harsh reality heightens the impor-
tance of making the best use of simple
tools, such as physical examination of
the retina, commonly neglected because
of the perception that it can only be per-
formed by an ophthalmologist and
because ophthalmology consultation
services in low-resource settings are vir-
tually nonexistent [9]. The solution is
“task shifting” to HIV clinicians, the
feasibility of which is documented in
this letter and in a report from
Myanmar, where trained HIV clinicians
routinely examine the retina by indirect
ophthalmoscopy to detect cytomegalovi-
rus retinitis [10].
Retinal examination is the least costly
and most rapid means of establishing a
diagnosis of disseminated tuberculosis. It
is a point-of-care service that can be im-
plemented on the ﬁrst visit and allows for
early diagnosis in patients with low CD4
cell counts and/or severe illness, who are
exactly those at highest risk of death.
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